ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
128.129,98
-0,30%
S&P 500
5.308,15
1,17%
US Dollar vs BRL
5,1359
0,13%
Bitcoin
66.094,38
7,38%
Brent Oil
82,735
0,22%
Registration Strip Icon for smarter Negocie de forma mais inteligente, não mais difícil: Libere seu potencial com nosso conjunto de ferramentas e discussões ao vivo.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Pieris Pharmaceuticals Inc (PIRS)

  7. Pieris Pharmaceuticals Inc (PIRS) Notícias

PIRS

Pieris Pharmaceuticals (PIRS)

Pieris Pharmaceuticals Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:PIRS
DataHoraFonteTítuloCódigoCompanhia
09/05/202409:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PIRSPieris Pharmaceuticals Inc
14/02/202418:37Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:PIRSPieris Pharmaceuticals Inc
14/11/202318:02Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:PIRSPieris Pharmaceuticals Inc
31/08/202317:15Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:PIRSPieris Pharmaceuticals Inc
10/08/202318:04Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:PIRSPieris Pharmaceuticals Inc
26/06/202318:26Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:PIRSPieris Pharmaceuticals Inc
23/06/202317:47Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PIRSPieris Pharmaceuticals Inc
12/06/202307:43Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:PIRSPieris Pharmaceuticals Inc
22/05/202318:01Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:PIRSPieris Pharmaceuticals Inc
11/05/202307:02Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:PIRSPieris Pharmaceuticals Inc
28/04/202317:22Edgar (US Regulatory)Annual Report to Security Holders (ars)NASDAQ:PIRSPieris Pharmaceuticals Inc
28/04/202317:20Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:PIRSPieris Pharmaceuticals Inc
31/03/202317:05Edgar (US Regulatory)Annual Report (10-k)NASDAQ:PIRSPieris Pharmaceuticals Inc
14/02/202318:19Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:PIRSPieris Pharmaceuticals Inc
03/01/202318:56Edgar (US Regulatory)Confidential Treatment Order (ct Order)NASDAQ:PIRSPieris Pharmaceuticals Inc
04/11/202218:11Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:PIRSPieris Pharmaceuticals Inc
04/08/202218:06Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:PIRSPieris Pharmaceuticals Inc
12/05/202207:02Edgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:PIRSPieris Pharmaceuticals Inc
29/04/202217:12Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:PIRSPieris Pharmaceuticals Inc
08/01/202211:15TipRanksAnalysts Offer Insights on Healthcare Companies: Neurocrine (NBIX), Pieris Pharmaceuticals (PIRS) and Biohaven Pharmaceutical Holding Co (BHVN)NASDAQ:PIRSPieris Pharmaceuticals Inc
16/08/202107:36Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:PIRSPieris Pharmaceuticals Inc
05/08/202117:49Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:PIRSPieris Pharmaceuticals Inc
25/06/202107:18TipRanksWhat Makes Penny Stock Pieris Pharma A “Strong Buy”?NASDAQ:PIRSPieris Pharmaceuticals Inc
01/06/202117:02Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:PIRSPieris Pharmaceuticals Inc
26/05/202119:37TipRanksPieris: Shares Can Still Soar Much Higher, Says AnalystNASDAQ:PIRSPieris Pharmaceuticals Inc
25/06/202018:00Edgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/a)NASDAQ:PIRSPieris Pharmaceuticals Inc
20/11/201910:10Edgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)NASDAQ:PIRSPieris Pharmaceuticals Inc
08/11/201811:00GlobeNewswire Inc.Pieris Pharmaceuticals to Present at Investor Conferences in NovemberNASDAQ:PIRSPieris Pharmaceuticals Inc
07/11/201810:00GlobeNewswire Inc.Pieris Pharmaceuticals Reports Third Quarter 2018 Financial Results and Provides Corporate UpdateNASDAQ:PIRSPieris Pharmaceuticals Inc
31/10/201809:00GlobeNewswire Inc.Pieris Pharmaceuticals to Host Third Quarter 2018 Investor Call and Corporate Update on November 7, 2018NASDAQ:PIRSPieris Pharmaceuticals Inc
 Apresentando as notícias mais relevantes sobre:NASDAQ:PIRS

Seu Histórico Recente

LSE
0IAU
Direxion Daily Financial...
LSE
BH11
Citi Fun 29
EU
MLPAC
Pacte Novation
NASDAQ
STNL
Sentinel Energy Services
EU
BPCLY
BPCE BPCE3.87%20JUN2024
Delayed Upgrade Clock
ADVFN Logo

Brasil
Empresa
Negócios
Popular
Obter o aplicativo

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados